Rocket Pharmaceuticals (RCKTW): which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
3 concentrated managers hold it with a median weight of 0.0%.
Quarter flow (concentrated managers)
Change in managers (3 → 3): 0 opened · 0 exited = 0
Net flow in the quarter: $0K (0 shares) · bought $0 and sold $0Shares concentrated managers added minus those they cut, valued at the 13F quarter-end implied price, not each trade's price. It is a different measure from the change in managers: the two can have opposite signs.
Concentrated managers holding it
- Sio Capital Management$1.5K0.0%
- RTW Investments$1.2K0.0%0.5% with RCKT
- Silverarc Capital Management$3560.0%
Up to 15, sorted by position value. The percentage is the weight in each manager's portfolio.
Largest holders of RCKTW (all 13F filers)
- Sio Capital Managementconcentrated400 KInvestment firm0
- RTW Investmentsconcentrated350 KInvestment firm0
- Citadel Advisors310 KQuant or multi-manager+373
- Walleye Capital284 KQuant or multi-manager0
- Silverarc Capital Managementconcentrated105 KInvestment firm0
- LMR Partners LLP76 KType not verified0
- Affinity Asset Advisors75 KInvestment firm0
- Boothbay Fund Management37 KType not verified0
- Ancora Advisors6,000Type not verified0
- Toronto Dominion Bank99Bank or trading desk+99
- Sio Capital Managementconcentrated
- Shares
- 400 K
- Change
- 0
See more
- Type
- Investment firm
- Value
- $1.5K
- RTW Investmentsconcentrated
- Shares
- 350 K
- Change
- 0
See more
- Type
- Investment firm
- Value
- $1.2K
- Shares
- 310 K
- Change
- +373
See more
- Type
- Quant or multi-manager
- Value
- $1.9K
- Shares
- 284 K
- Change
- 0
See more
- Type
- Quant or multi-manager
- Value
- $1.4K
- Silverarc Capital Managementconcentrated
- Shares
- 105 K
- Change
- 0
See more
- Type
- Investment firm
- Value
- $356
- Shares
- 76 K
- Change
- 0
See more
- Type
- Type not verified
- Value
- $364
- Shares
- 75 K
- Change
- 0
See more
- Type
- Investment firm
- Value
- $278
- Shares
- 37 K
- Change
- 0
See more
- Type
- Type not verified
- Value
- $126
- Shares
- 6,000
- Change
- 0
See more
- Type
- Type not verified
- Value
- $22
- Shares
- 99
- Change
- +99
See more
- Type
- Bank or trading desk
- Value
- $49
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
Insiders (Form 4)
Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.
Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →
Above 5% (13D/13G)
This list may be incomplete: we hold 13D and 13G filings made since December 2024. A holder above 5% that has not filed anything since then is not shown here.
No recent filings.
All material events (8-K)
Earnings, agreements, financing, management changes and announcements from the last year, with a filter by type and a link to each filing.